Contact Us
Drug Search Results
More Filters [+]

Colestilan

Alternative Names: colestilan, mci-196, mci196, mci 196
Latest Update: 2023-06-19
Latest Update Note: PubMed Publication

Product Description

Mechanisms of Action: Phosphate Binder

Novel Mechanism: No

Modality: Small Molecule

Route of Administration: Oral

FDA Designation: None *

Approval Status: Not Approved

Approved Countries: European Medicines Agency | Germany | Ireland | Italy | Portugal | Sweden | United Kingdom

Approved Indications: None

Known Adverse Events: None

Company: Mitsubishi Tanabe
Company Location:
Company CEO:
Additonal Commercial Interests: None

Clinical Description

Map of Global Clinical Trials for Colestilan

Countries in Clinic:

Active Clinical Trial Count:

Highest Development Phases

Phase 3: Kidney Failure, Chronic|Hyperphosphatemia|Kidney Diseases|Dyslipidemia

Phase 2: Type 2 Diabetes

Phase 1: Kidney Failure, Chronic|Hyperphosphatemia

Trial

Phase

Trial Status

Disease

Primary Completion Date

Probability of Success
2012-002583-27

P3

Terminated

Hyperphosphatemia|Kidney Diseases

2017-01-11

2012-002581-12

P3

Completed

Hyperphosphatemia|Kidney Diseases

2015-01-26

MCI-196-E14

P3

Terminated

Kidney Failure, Chronic|Hyperphosphatemia

2015-01-01

2012-002582-35

P3

Terminated

Hyperphosphatemia|Kidney Diseases

2014-12-17

Recent News Events

Date

Type

Title

06/19/2023

PubMed

 Bile Acid Sequestrants Based on Natural and Synthetic Gels.

01/01/2021

PubMed

 The Rising Risk of Chronic Kidney Disease (CKD) and How it is Dealt with: A Review of Current and Potential Phosphate Binders (PB).

06/01/2020

PubMed

 Phosphate binders in chronic kidney disease: an updated narrative review of recent data.

Did PRYZM just deliver the data you were looking for?
Did you try our Excel download too?

Now that you’ve used PRYZM, we hope you’re able to see for yourself that it was designed and developed by people who actually use this data for a living. By applying next-generation technology for aggregating and curating this info across multiple key sources PRYZM delivering the latest information at your fingertips just the way you need it and with industry leading speed and cost effectiveness.

Our subscribers enjoy unlimited searches and receive this data on their own secure instance so they can overlay any additional internal/proprietary data on top of the search results and blend that data with real-time industry intel from PRYZM. Discover how you can continue to uncover the competitive landscape and drive strategy.

Suggestions